Abstract:Cytotoxic CD8 + T cells are key eVectors in the immunotherapy of malignant and viral diseases. However, autologous T cell responses to tumor antigens presented by self-MHC are usually weak and ineVective. Allo-restricted T cells represent a potent source of tumor-speciWc T cells for adoptive immunotherapy. This study reports in vivo anti-melanoma eYcacy of the pTRP2-speciWc allo-restricted CTLs expanded from the BALB/c splenocytes by multiple stimulations with aAPCs made by coating H-2K b -Ig/pTRP2 dimeric com- plexes, anti-CD28 antibody, 4-1BBL molecules and CD83 molecules to cell-sized latex beads. The induced allo-restricted CTLs exhibited speciWc lysis against RMA-S cells pulsed with the peptide pTRP2 and H-2K b+ melanoma cells expressing TRP2, while a murine Lewis lung carcinoma cell line 3LL could not be recognized by the CTLs. The peptide-speciWc activity was inhibited by anti-H-2K b monoclonal antibody Y3. Adoptive transfer of the allo-restricted CTLs speciWc for malignant mela- noma expanded by the aAPCs can mediate eVective anti- melanoma response in vivo. These results suggested that the speciWc allo-restricted CTLs expanded by aAPCs coated with an MHC-Ig/peptide complex, anti-CD28 antibody, 4-1BBL and CD83 could be a potential option of speciWc immunotherapy for patients with malignant melanoma.

In Vivo Anti-Melanoma Eycacy of Allo-Restricted CTLs Speciwc for Melanoma Expanded by Artiwcial Antigen-Presenting Cells